Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery Synaptophysin
Path
Created with Sketch.
Go to Synaptophysin Normal Tissue Gallery
Go back to Product Page
Adrenal gland - Adrenocortical adenoma with a weak to moderate , mostly membranous Synaptophysin immunostaining in about 50% of tumor cells.
Adrenal gland – Adrenocortical adenoma with a weak to moderate , mostly membranous Synaptophysin immunostaining in about 50% of tumor cells.
Adrenal gland - Adrenocortical adenoma with a weak Synaptophysin immunostaining in few tumor cells.
Adrenal gland – Adrenocortical adenoma with a weak Synaptophysin immunostaining in few tumor cells.
Adrenal gland - Moderate to strong Synaptophysin positivity in an adrenocortical adenoma.
Adrenal gland – Moderate to strong Synaptophysin positivity in an adrenocortical adenoma.
Adrenal gland - Pheochromocytoma with strong, diffuse Synaptophysin positivity in all tumor cells.
Adrenal gland – Pheochromocytoma with strong, diffuse Synaptophysin positivity in all tumor cells.
Breast - Invasive breast cancer of no special type (NST) exhibiting a weak to moderate Synaptophysin immunostaining of all tumor cells.
Breast – Invasive breast cancer of no special type (NST) exhibiting a weak to moderate Synaptophysin immunostaining of all tumor cells.
Breast - Synaptophysin negative invasive breast cancer of no special type (NST).
Breast – Synaptophysin negative invasive breast cancer of no special type (NST).
Lung - Small cell carcinoma showing a moderate Synaptophysin immunostaining of all tumor cells.
Lung – Small cell carcinoma showing a moderate Synaptophysin immunostaining of all tumor cells.
Lung - Synaptophysin negative adenocarcinoma.
Lung – Synaptophysin negative adenocarcinoma.
Pancreas - Neuroendocrine tumor exhibiting strong cytoplasmic Synaptophysin immunostaining of tumor cells.
Pancreas – Neuroendocrine tumor exhibiting strong cytoplasmic Synaptophysin immunostaining of tumor cells.
Prostate - Synaptophysin negative adenocarcinoma (Gleason 3+3=6).
Prostate – Synaptophysin negative adenocarcinoma (Gleason 3+3=6).
Prostate - Synaptophysin positive adenocarcinoma (Gleason 5+5=10).
Prostate – Synaptophysin positive adenocarcinoma (Gleason 5+5=10).
Retroperitoneum - Diffuse, moderate to strong Synaptophysin immunostaining of all cells of a leiomyosarcoma.
Retroperitoneum – Diffuse, moderate to strong Synaptophysin immunostaining of all cells of a leiomyosarcoma.
Skin - Merkel cell carcinoma displaying an intense cytoplasmic Synaptophysin immunostaining of all tumor cells.
Skin – Merkel cell carcinoma displaying an intense cytoplasmic Synaptophysin immunostaining of all tumor cells.
Skin - Synaptophysin negative basal cell carcinoma.
Skin – Synaptophysin negative basal cell carcinoma.
Stomach - Synaptophysin negative adenocarcinoma (intestinal type).
Stomach – Synaptophysin negative adenocarcinoma (intestinal type).
Thyroid - Medullary carcinoma with strong cytoplasmic Synaptophysin immunostaining of all tumor cells.
Thyroid – Medullary carcinoma with strong cytoplasmic synaptophysin immunostaining of all tumor cells.
Urinary bladder - Small cell carcinoma with diffuse, intense cytoplasmic Synaptophysin positivity.
Urinary bladder – Small cell carcinoma with diffuse, intense cytoplasmic Synaptophysin positivity.